Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
View Top Employees from Aclaris Therapeutics, Inc.Website | http://www.aclaristx.com/ |
Ticker | ACRS |
Revenue | $10 million |
Funding | $169.5 million |
Employees | 75 (75 on RocketReach) |
Founded | 2012 |
Address | 640 Lee Rd, Wayne, Pennsylvania 19087, US |
Phone | (484) 324-7933 |
Fax | (484) 320-2344 |
Technologies |
JavaScript,
HTML,
Google Analytics
+24 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
Web Rank | 2 Million |
Keywords | Aclaris Therapeutics, Aclaris, Ati-1777 Aclaris Therapeutics Inc, Aclaris As Ati-502 (Topical) And Ati-501, Patent Press Release |
Competitors | Flexion Therapeutics, Novan, Inc., Presidio Pharmaceuticals, Inc., Quince Therapeutics, TARIS Bio |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Aclaris Therapeutics, Inc. employee's phone or email?
The Aclaris Therapeutics, Inc. annual revenue was $10 million in 2024.
Kevin Balthaser is the CFO of Aclaris Therapeutics, Inc..
75 people are employed at Aclaris Therapeutics, Inc..
Aclaris Therapeutics, Inc. is based in Wayne, Pennsylvania.
The NAICS codes for Aclaris Therapeutics, Inc. are [3254, 32, 32541, 325].
The SIC codes for Aclaris Therapeutics, Inc. are [28, 283].